10.3390/cells10051161 108 YeM.FuS.PiR.HeF
11 However, a dose-specific analysis revealed that the beneficial effect of efpeglenatide on HF hospitalisation was primarily seen in the 6 mg group, in which there was a 50% RRR in HF hospitalisation (HR 0.50)
The meta-analysis of the ELIXA, LEADER, SUSTAIN-6, EXSCEL, Harmony, PIONEER 6, REWIND and AMPLITUDE-O trials shows that the extent of HbA 1c reduction may serve as a proxy for the renal benefits of GLP-1RA therapy
It is addressing the ferritin, the cortisol, the gut, the hormones, the diet, and the sleep all at once instead of treating each one in isolation
It is also unclear whether it interacts with any medications